Error: Could not add to watchlist. X

Oasmia Pharmaceutical AB

+ Watchlist
OMAX:GR
Frankfurt
1.89
EUR
0.01
0.43%
As of 13:35:37 ET on 07/31/2015.
Open
1.85
Day Range
1.81 - 1.89
Volume
0
Previous Close
1.88
52Wk Range
1.73 - 2.43
1 Yr Return
-20.68%
Open
1.85
Day Range
1.81 - 1.89
Volume
0
Previous Close
1.88
52Wk Range
1.73 - 2.43
1 Yr Return
-20.68%
YTD Return
-8.44%
Current P/E Ratio (TTM)
-
Earnings per Share (SEK) (TTM)
-
Market Cap (m EUR)
184.658
Shares Outstanding (m)
97.858
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.
ADDRESS
Vallongatan 1
Uppsala, 752 28
Sweden
PHONE
46-1850-5440
  • Julian Aleksov
    Chairman/President/Co-Founder
  • Mikael Asp
    Chief Executive Officer
  • Anders Blom
    Exec Vice President
  • Margareta Eriksson
    VP:Clinical Development
  • Ingela Hagglund
    VP:Operations
Show More